|
Michael Schuppenhauer: CEO & President of the US Operations, Farmatic Inc.Michael R. Schuppenhauer, Ph.D., has over 25 years of scientific, engineering, finance and business experience in cleantech, renewable energy and biosciences. He is since 2011 the CEO & President of the US operations of Farmatic.Previously, Michael was Vice President at Fleishman-Hillard in the area of strategic communications and public policy at state and federal level, andSenior Editor and Director of Business Development with BioCentury Publications, Inc. Prior, he was in Paris, France withHambrecht & Quist (now JP Morgan) generating and executing corporate finance business across Europe. Before that, he was with McKinsey & Company in Zurich, Brussels and Stockholm, andworked as a project manager with Prognos AG in Basel and Munich. He advised the German and Swiss federal governments on their economic strategies by kick-starting emerging company growth. He has also served in preparation of a large global merger, rose close to $100 million for two IPOs, and established and raised two successful biotech venture funds.Michael holds an M.Sc.in Chemical Engineering from the Technical University of Hamburg in Germany and a Ph.D. degree in Chemical Engineering from the Swiss Federal Institute of Technology (ETH Zurich). In 1991 he was a visiting researcher at the University of California, Berkeley for his master’s thesis on thermophilic microorganisms, and in 1990 with Ciba-Geigy in Basel, Switzerland. |
|
|